Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial

Abroad (travel likely)RecruitingPHASE3

Conditions

Cisplatin-related Hearing Loss

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Antoni van Leeuwenhoek, Amsterdam, North Holland, Netherlands
Contact: Study coordinator (Daniël Griffioen, MD) · da.griffioen@nki.nl · +31205129111
Contact: Study coordinator (Jeany Rademaker-Lakhai, PhD) · j.lakhai@nki.nl · +31205129111
Contact: Principal Investigator (Lotje Zuur)
Leiden University Medical Center, Leiden, South Holland, Netherlands
Contact: Study coordinator (Jeroen Jansen, Prof.) · J.c.jansen@lumc.nl · +31715269111
Contact: Principal Investigator (Jeroen Jansen, Prof.)
Erasmus Universitair Medisch Centrum Rotterdam, Rotterdam, South Holland, Netherlands
Contact: Study coordinator (Stijn Keereweer, Dr.) · s.keereweer@erasmusmc.nl · +31107040704
Contact: Principal Investigator (Stijn Keereweer, Dr.)
University Medical Center Utrecht, Utrecht, Utrecht, Netherlands
Contact: Study coordinator (Robert Stokroos, Prof.) · R.J.Stokroos@umcutrecht.nl · +31887555555
Contact: Principal Investigator (Robert Stokroos, Prof.)
Stichting Radboud University Medical Center, Nijmegen, Netherlands
Contact: Study coordinator (Froukje Cals, Dr.) · Froukje.Cals@radboudumc.nl · +31243611111
Contact: Principal Investigator (Froukje Cals, Dr.)

Study leads

Lotje Zuur, Prof. Dr.
Principal Investigator
AVL

View source on ClinicalTrials.gov Contact study team (email)